<DOC>
	<DOCNO>NCT00580216</DOCNO>
	<brief_summary>The objective evaluate whether weekly subcutaneous ( SC ) injection idrabiotaparinux sodium ( biotinylated idraparinux ) least efficient prevent clot brain organs oral international normalize ratio ( INR ) adjusted-dose warfarin patient atrial fibrillation ( AF ) .</brief_summary>
	<brief_title>Evaluation Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin Prevent Stroke Systemic Thromboembolic Events Patients With Atrial Fibrillation</brief_title>
	<detailed_description>The end study define common study end date participant , define 9 month ( 39 week ) last participant randomize . All participant receive oral warfarin ( match placebo ) weekly SC injection idrabiotaparinux sodium ( match placebo ) 6 month common study end date . All participant expect treat least 6 month . All participant 6-month observational period cessation study treatment .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>SANORG 34006</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Biotin</mesh_term>
	<criteria>Non valvular atrial fibrillation ( AF ) Indication longterm VitaminK antagonist ( VKA ) therapy base presence previous ischemic stroke , transient ischemic attack ( TIA ) systemic embolism and/or least two follow risk factor : hypertension require drug treatment , moderately severely impaired leave ventricular function and/or congestive heart failure , age &gt; = 75 year , diabetes mellitus . Main exclusion Criteria : Indication VKA AF Stroke TIA within previous 5 day Transient AF cause reversible disorder Planned major surgery/trauma cardioversion within 30 day INR &gt; 3 baseline Active bleeding high risk bleed Uncontrolled hypertension Pregnancy childbearing potential without proper contraceptive measure breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>systemic thromboembolic event</keyword>
</DOC>